CH-223191

CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist with IC50 of 30 nM.

CH-223191 Chemical Structure

CH-223191 Chemical Structure

CAS: 301326-22-7

Selleck's CH-223191 has been cited by 39 publications

Purity & Quality Control

Batch: Purity: 99.75%
99.75

Products often used together with CH-223191

PD98059


CH-223191 and PD98059 abolish TCDD-induced ERK1/2 phosphorylation and cell proliferation in human colon cancer cells.

Xie G, et al. Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G1006-15.

Venetoclax (ABT-199)


CH-223191 and Venetoclax use exhibit synergistic or additive cytotoxicity in CLL cells.

Atene CG, et al. Front Immunol. 2022 Mar 18;13:832263.

FICZ


CH223191 is intraperitoneally administered 1 hr before FICZ application to modulate AhR activation.

Zhao C, et al. PLoS Pathog. 2021 Jul 23;17(7):e1009774.

GNF351


CH-223191 and GNF351 are AhR antagonists that completely inhibit the VRCZ-induced transcription of CYP1A1 and COX-2 in HaCaT cells.

Ikeya S, et al. Sci Rep. 2018; 8: 5050.

Doxorubicin


CH-223191 blocks doxorubicin-mediated AhR activation and inhibits the increase in CYP1A1 and GSTA1 in vitro.

Volkova M, et al. Cardiovasc Res. 2011;90(2):305-314.

CH-223191 Related Products

Choose Selective AhR Inhibitors

Biological Activity

Description CH-223191 is a potent and specific aryl hydrocarbon receptor (AhR) antagonist with IC50 of 30 nM.
Targets
AhR [1]
(in HepG2 cells)
30 nM
In vitro
In vitro

CH-223191 blocks TCDD-mediated nuclear translocation and DNA binding of AhR, and also causes the inhibition of TCDD-induced cytochrome P450 enzyme activity. [1]

In human glioblastoma cells, CH-223191downregulates the TGF-beta/Smad pathway, and reduces clonogenic survival and invasiveness. [2]

In SK-N-SH human-derived neuronal cells, CH223191 counteracts the TCDD-induced suppression of neuronal acetylcholinesterase expression. [3]

In endothelial cells, CH-223191 potentiates ICAM-1 expression and prevents RelB nuclear translocation. [4]

Kinase Assay Luciferase Reporter Gene Assay
The cells are lysed with lysis buffer (20 mM Tris-HCl, pH 7.8, 1% Triton X-100, 150 mM NaCl, and 2 mM dithiothreitol). The cell lysate is mixed with luciferase activity assay reagent and luminescence produced for 5 s is measured using a luminometer.
Cell Research Cell lines HepG2 cells
Concentrations 30 nM
Incubation Time 1 h
Method

HepG2 cells were treated with the various concentrations of CH-223191 or flavone for 1 h and then with 3 nM TCDD for 24 h, and then luciferase activity was assayed.

Experimental Result Images Methods Biomarkers Images PMID
Western blot hpol κ / γH2AX 26651356
In Vivo
In vivo

CH-223191 (10 mg/kg/day, p.o.) potently prevents TCDD-caused cytochrome P450 induction, liver toxicity, and wasting syndrome in mice. [1]

Animal Research Animal Models Male ICR mice
Dosages 10 mg/kg/day
Administration p.o.

Chemical Information & Solubility

Molecular Weight 333.39 Formula

C19H19N5O

CAS No. 301326-22-7 SDF Download CH-223191 SDF
Smiles CC1=CC=CC=C1N=NC2=CC(=C(C=C2)NC(=O)C3=CC=NN3C)C
Storage (From the date of receipt)

In vitro
Batch:

DMSO : 67 mg/mL ( (200.96 mM); Moisture-absorbing DMSO reduces solubility. Please use fresh DMSO.)

Water : Insoluble

Ethanol : Insoluble


Molecular Weight Calculator

In vivo
Batch:

Add solvents to the product individually and in order.


In vivo Formulation Calculator

Preparing Stock Solutions

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy CH-223191 | CH-223191 supplier | purchase CH-223191 | CH-223191 cost | CH-223191 manufacturer | order CH-223191 | CH-223191 distributor